Group A streptococcus
The Boston-based company has developed a loop-mediated amplification assay and a novel lateral flow strip technology.
Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M
The firm sells a rapid, point-of-care, PCR platform for infectious disease diagnostics, including SARS-CoV-2, influenza, respiratory syncytial virus, and strep A.
Mesa Biotech Receives 510(k) Clearance, CLIA Waiver for Strep A Molecular Point-of-Care Test
The firm said its test fits in the palm of a hand and delivers results in 30 minutes by detecting bacterial nucleic acid in throat, nasal, or nasopharyngeal swabs.
A. Menarini to Distribute Credo Diagnostics Coronavirus Assay Kit, Respiratory Infection Assays
Credo Diagnostics recently received the CE mark for the coronavirus test, which can provide results in 20 minutes.
Strep A Sequences Point to Potential Scarlet Fever Culprit in the UK
Researchers identified Streptococcus pyogenes isolates from a lineage dubbed M1UK that are predicted to produce higher-than-usual levels of a scarlet fever-associated toxin.